Skip to the page

Data / Form D filings / CTRL Therapeutics USA, Inc.

CTRL Therapeutics USA, Inc.: Form D filings

CTRL Therapeutics USA, Inc., a biotechnology company in Glencoe, IL, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on September 27, 2024, reports $9.1 million sold of a $10 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
655 SHERIDAN RD, Glencoe, IL, 60022
Phone
(415) 640-8884
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1951690

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 27, 2024New notice$9,999,998$9,135,991$864,0075Sep 19, 2024sec.gov
Oct 27, 2022New notice$10,617,815$7,502,901$3,114,9147Oct 12, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Derrell PorterExecutive Officer, Director
Collin ToddDirector
David O'NeillDirector
Shana KelleyExecutive Officer, Director

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Sep 23, 2024 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what CTRL Therapeutics USA, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.